Cargando…
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma
Medulloblastoma, the most common pediatric malignant brain tumor, continues to have a high rate of morbidity and mortality in childhood. Recent advances in cancer genomics, single-cell sequencing, and sophisticated tumor models have revolutionized the characterization and stratification of medullobl...
Autores principales: | Zou, Han, Poore, Brad, Broniscer, Alberto, Pollack, Ian F., Hu, Baoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139663/ https://www.ncbi.nlm.nih.gov/pubmed/32164294 http://dx.doi.org/10.3390/cancers12030643 |
Ejemplares similares
-
MBRS-63. THE ROLE OF THE SWI/SNF COMPLEX SUBUNIT SMARCD3 IN MEDULLOBLASTOMA
por: Poore, Brad, et al.
Publicado: (2020) -
MEDB-88. BAF60C/SMARCD3-mediated novel neurodevelopmental epigenomic program promotes metastatic dissemination in medulloblastoma
por: Zou, Han, et al.
Publicado: (2022) -
Spatial heterogeneity in medulloblastoma
por: Morrissy, A Sorana, et al.
Publicado: (2017) -
A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis
por: Zou, Han, et al.
Publicado: (2023) -
Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment
por: Rechberger, Julian S., et al.
Publicado: (2023)